Marrone Bio Innovations Company Profile (NASDAQ:MBII)

About Marrone Bio Innovations

Marrone Bio Innovations logoMarrone Bio Innovations, Inc. offers bio-based pest management and plant health products. The Company's bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene. Its products are used in both conventional and organic crop production, and are sold to growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens and ornamental plants. It offers Regalia for large-acre row crops, such as corn and soybeans. Its pipeline of early-stage discoveries and product candidates extends across a range of product types for end markets, including herbicides, fungicides, nematicides, insecticides, algaecides (for algae control), molluscicides (for mussel and snail control), and plant growth and plant stress regulators. It is engaged in developing MBI-010, MBI-110, Haven (MBI-505) and MBI-601.

Industry, Sector and Symbol:
  • Sector: Basic Materials
  • Industry: Agricultural Chemicals
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: MBII
  • CUSIP:
Key Metrics:
  • Previous Close: $2.06
  • 50 Day Moving Average: $2.20
  • 200 Day Moving Average: $1.95
  • 52-Week Range: $0.60 - $2.79
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.61
  • P/E Growth: 0.00
  • Market Cap: $50.80M
  • Outstanding Shares: 24,658,000
  • Beta: 0.46
Profitability:
  • Net Margins: -258.51%
  • Return on Assets: -56.17%
Debt:
  • Debt-to-Equity Ratio: -2.48%
  • Current Ratio: 2.44%
  • Quick Ratio: 1.77%
Additional Links:
Companies Related to Marrone Bio Innovations:

Analyst Ratings

Consensus Ratings for Marrone Bio Innovations (NASDAQ:MBII) (?)
Ratings Breakdown: 1 Hold Rating, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $2.33 (13.27% upside)

Analysts' Ratings History for Marrone Bio Innovations (NASDAQ:MBII)
Show:
DateFirmActionRatingPrice TargetDetails
11/23/2016Jefferies Group LLCBoost Price TargetHold$1.50 -> $2.50View Rating Details
5/14/2016Piper Jaffray CompaniesReiterated RatingOverweight$2.00 -> $1.00View Rating Details
3/16/2016HC WainwrightReiterated RatingBuyView Rating Details
3/16/2016Rodman & RenshawInitiated CoverageBuy$3.50View Rating Details
12/31/2015Roth CapitalReiterated RatingBuy -> Not Rated$15.00View Rating Details
(Data available from 2/27/2015 forward)

Earnings

Earnings History for Marrone Bio Innovations (NASDAQ:MBII)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/28/2017        
11/14/2016Q316($0.22)($0.29)$3.66 millionViewN/AView Earnings Details
8/9/2016Q216($0.28)($0.28)$4.61 million$5.00 millionViewN/AView Earnings Details
5/12/2016Q116($0.27)($0.38)$3.05 million$2.70 millionViewListenView Earnings Details
3/30/2016Q215($0.40)($0.45)$1.10 million$1.90 millionViewListenView Earnings Details
8/7/2014($0.47)($0.50)ViewN/AView Earnings Details
5/13/2014Q114($0.38)($0.52)$4.63 million$2.80 millionViewN/AView Earnings Details
3/6/2014($0.40)($0.52)ViewN/AView Earnings Details
9/12/2013Q2 2013($0.33)($2.36)$4.33 million$4.50 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Marrone Bio Innovations (NASDAQ:MBII)
Current Year EPS Consensus Estimate: $-1.19 EPS
Next Year EPS Consensus Estimate: $-0.79 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20161($0.29)($0.29)($0.29)
Q4 20161($0.35)($0.35)($0.35)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Marrone Bio Innovations (NASDAQ:MBII)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Marrone Bio Innovations (NASDAQ:MBII)
Insider Ownership Percentage: 7.25%
Institutional Ownership Percentage: 37.95%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/15/2016Richard E RomingerDirectorBuy10,000$0.94$9,400.00View SEC Filing  
6/13/2016James BoydCFOBuy10,000$0.79$7,900.00View SEC Filing  
6/9/2016George H KerckhoveDirectorBuy2,500$0.72$1,800.00View SEC Filing  
6/9/2016Pamela G MarroneCEOBuy5,000$0.72$3,600.00View SEC Filing  
6/9/2016Timothy B JohnsonVPBuy10,000$0.72$7,200.00View SEC Filing  
8/14/2014George H KerckhoveDirectorBuy400$5.90$2,360.00View SEC Filing  
8/12/2014Pamela G MarroneCEOBuy1,000$5.29$5,290.00View SEC Filing  
2/12/2014Ventures Pte. Ltd. Syngentamajor shareholderSell332,027$14.72$4,887,437.44View SEC Filing  
1/29/2014Donald GlidewellCFOSell75,495$17.00$1,283,415.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Marrone Bio Innovations (NASDAQ:MBII)
DateHeadline
News IconInvestors are Looking at Levels for Marrone Bio Innovations Inc (MBII) - The Standard (NASDAQ:MBII)
6milestandard.com - February 25 at 8:17 AM
globenewswire.com logoMarrone Bio Innovations Hosts Grower Nematicide Training - GlobeNewswire (press release) (NASDAQ:MBII)
globenewswire.com - February 21 at 6:29 PM
finance.yahoo.com logoMarrone Bio Innovations Hosts Grower Nematicide Training (NASDAQ:MBII)
finance.yahoo.com - February 21 at 6:29 PM
News IconMarrone Bio Innovations, Inc. (MBII) Under Analyst Spotlight - UK Market News (NASDAQ:MBII)
www.ukmarketnews.co.uk - February 17 at 2:15 PM
News IconIs there Upside to Marrone Bio Innovations, Inc. (NASDAQ:MBII) ? - Rockville Register (NASDAQ:MBII)
rockvilleregister.com - February 17 at 2:15 PM
nasdaq.com logoMarrone Bio Innovations and Groundwork BioAg Bio-stacked Microbial Seed Treatments Result in Increased Corn and ... - Nasdaq (NASDAQ:MBII)
www.nasdaq.com - February 14 at 7:57 PM
us.rd.yahoo.com logoMarrone Bio Innovations and Groundwork BioAg Bio-stacked Microbial Seed Treatments Result in Increased Corn and Soybean Yields (NASDAQ:MBII)
us.rd.yahoo.com - February 13 at 10:23 AM
finance.yahoo.com logoMarrone Bio Innovations to Hold Bioinsecticides Webinar (NASDAQ:MBII)
finance.yahoo.com - February 10 at 7:15 PM
investornewswire.com logoMarrone Bio Innovations, Inc. (NASDAQ:MBII) EPS Target At $-0.17 - Investor Newswire (NASDAQ:MBII)
www.investornewswire.com - February 7 at 7:44 PM
bizjournals.com logoMarrone Bio preparing to sell to the cannabis industry (NASDAQ:MBII)
www.bizjournals.com - February 3 at 7:09 PM
News IconBroker Changes For Marrone Bio Innovations, Inc. (MBII) - NewsDen (NASDAQ:MBII)
newsden.net - February 2 at 7:16 PM
News IconTechnical Focus: Williams %R, ADX, and CCI Levels for Marrone Bio Innovations Inc. (MBII) - Sherwood Daily (NASDAQ:MBII)
sherwooddaily.com - February 1 at 12:19 AM
News IconNewsworthy Wonder Stock: Penny Stock Investors Looking at Marrone Bio Innovations, Inc. (NASDAQ:MBII) - Nelson Research (NASDAQ:MBII)
nelsonobserver.com - February 1 at 12:19 AM
News IconEarnings According to Analysts for Marrone Bio Innovations, Inc. (NASDAQ:MBII)? - Aiken Advocate (NASDAQ:MBII)
aikenadvocate.com - February 1 at 12:19 AM
News IconIs the Needle Ready to Move for Marrone Bio Innovations, Inc. (NASDAQ:MBII) - Prospect Journal (NASDAQ:MBII)
prospectjournal.com - February 1 at 12:19 AM
News IconIs There Any Upside to This Stock Under $5: Marrone Bio Innovations, Inc. (NASDAQ:MBII) - Prospect Journal (NASDAQ:MBII)
prospectjournal.com - January 31 at 5:43 AM
bizjournals.com logoMarrone Bio inks deal to sell into $300 million Australia, New Zealand market - Sacramento Business Journal (NASDAQ:MBII)
www.bizjournals.com - January 31 at 12:10 AM
News IconNufarm Inks Deal To Market Marrone Bioinsecticide In ANZ (NASDAQ:MBII)
agfax.com - January 30 at 7:07 PM
us.rd.yahoo.com logoMarrone Bio Innovations and Nufarm Join Forces to Improve Crop Productivity and Sustainability for Growers in New Zealand and Australia (NASDAQ:MBII)
us.rd.yahoo.com - January 30 at 7:07 PM
bizjournals.com logoMarrone Bio inks deal to sell into $300 million Australia, New Zealand market (NASDAQ:MBII)
www.bizjournals.com - January 30 at 7:07 PM
News IconConsensus Estimates on Earnings & Stock Price in Focus for Marrone Bio Innovations, Inc. (NASDAQ:MBII) Shares - Aiken Advocate (NASDAQ:MBII)
aikenadvocate.com - January 26 at 8:24 PM
capitalcube.com logoETFs with exposure to Marrone Bio Innovations, Inc. : January 24, 2017 (NASDAQ:MBII)
www.capitalcube.com - January 24 at 7:10 PM
News IconInvestor Sphere: Keeping an Eye on Levels for Marrone Bio Innovations Inc. (MBII) - Sherwood Daily (NASDAQ:MBII)
sherwooddaily.com - January 23 at 6:43 PM
News IconTrading Indicator Check on Marrone Bio Innovations Inc. (MBII) - Sherwood Daily (NASDAQ:MBII)
sherwooddaily.com - January 20 at 7:12 PM
News IconPlacing the Bulls-Eye Focus on Marrone Bio Innovations, Inc. (NASDAQ:MBII) - Prospect Journal (NASDAQ:MBII)
prospectjournal.com - January 17 at 11:50 PM
investornewswire.com logoConsensus Rating Of Marrone Bio Innovations, Inc. (NASDAQ:MBII) At {{RATING_MEAN:40}} - Investor Newswire (NASDAQ:MBII)
www.investornewswire.com - January 16 at 6:59 PM
News IconStreetwise Investors Taking Note of Marrone Bio Innovations, Inc. (NASDAQ:MBII) - Prospect Journal (NASDAQ:MBII)
prospectjournal.com - January 13 at 5:00 AM
News IconBargain Hunter's Delight: What's the Latest on Marrone Bio Innovations, Inc. (NASDAQ:MBII) - Prospect Journal (NASDAQ:MBII)
prospectjournal.com - January 11 at 3:20 PM
News IconInvestors Swarm in on Marrone Bio Innovations, Inc. (NASDAQ:MBII) - Prospect Journal (NASDAQ:MBII)
prospectjournal.com - January 11 at 12:23 AM
capitalcube.com logoETFs with exposure to Marrone Bio Innovations, Inc. : January 9, 2017 (NASDAQ:MBII)
www.capitalcube.com - January 9 at 4:38 PM
publicnow.com logoAlbaugh Launches BIOST™ the First Complete Biological Seed Treatment Platform (NASDAQ:MBII)
www.publicnow.com - January 6 at 7:06 PM
capitalcube.com logoETFs with exposure to Marrone Bio Innovations, Inc. : December 30, 2016 (NASDAQ:MBII)
www.capitalcube.com - December 30 at 6:48 PM
capitalcube.com logoETFs with exposure to Marrone Bio Innovations, Inc. : December 13, 2016 (NASDAQ:MBII)
www.capitalcube.com - December 13 at 6:53 PM
News IconWhy a Davis biotech company is raising new capital (NASDAQ:MBII)
www.sacbee.com - December 9 at 11:31 PM
reuters.com logoBRIEF-Marrone Bio files for mixed shelf of up to $50 million (NASDAQ:MBII)
www.reuters.com - December 9 at 11:31 PM
us.rd.yahoo.com logoMarrone Bio Innovations’ Regalia® Maxx Biofungicide Approved in Chile (NASDAQ:MBII)
us.rd.yahoo.com - December 6 at 10:01 AM
thestreet.com logoMarrone Bio Innovations' Regalia® Maxx Biofungicide Approved In Chile (NASDAQ:MBII)
www.thestreet.com - December 5 at 10:30 AM
capitalcube.com logoETFs with exposure to Marrone Bio Innovations, Inc. : November 30, 2016 (NASDAQ:MBII)
www.capitalcube.com - November 30 at 6:35 PM
us.rd.yahoo.com logo8:32 am Marrone Bio Innovations receives registration of MBI-601 EP, a biofumigant, from the US EPA Biopesticide Pollution Prevention Division (NASDAQ:MBII)
us.rd.yahoo.com - November 30 at 11:13 AM
businesswire.com logoMarrone Bio Innovations Receives EPA Registration for New Biofumigant (NASDAQ:MBII)
www.businesswire.com - November 29 at 2:58 PM
capitalcube.com logoMarrone Bio Innovations, Inc. :MBII-US: Earnings Analysis: Q3, 2016 By the Numbers : November 29, 2016 (NASDAQ:MBII)
www.capitalcube.com - November 29 at 2:58 PM
businesswire.com logoMarrone Bio Innovations Receives California Approval for MAJESTENE ® Bionematicide (NASDAQ:MBII)
www.businesswire.com - November 18 at 8:49 AM
bizjournals.com logoCalifornia approval opens large market for Marrone Bio product (NASDAQ:MBII)
www.bizjournals.com - November 16 at 6:23 PM
finance.yahoo.com logo10:49 am Marrone Bio Innovations receives California DPR approval for Majestene Bionematicide (NASDAQ:MBII)
finance.yahoo.com - November 16 at 6:23 PM
seekingalpha.com logoMarrone Bio Innovations' (MBII) CEO Pamela Marrone on Q3 2016 Results - Earnings Call Transcript (NASDAQ:MBII)
seekingalpha.com - November 15 at 9:45 AM
4-traders.com logoMarrone Bio Innovations : Davis biotech firm shrinks quarterly losses (NASDAQ:MBII)
www.4-traders.com - November 15 at 9:45 AM
businesswire.com logoMarrone Bio Innovations Reports Third Quarter 2016 Results (NASDAQ:MBII)
www.businesswire.com - November 14 at 6:24 PM
biz.yahoo.com logoQ3 2016 Marrone Bio Innovations Inc Earnings Release - After Market Close (NASDAQ:MBII)
biz.yahoo.com - November 14 at 10:07 AM
finance.yahoo.com logoMarrone Bio Innovations Announces Date for Third Quarter 2016 Financial Results (NASDAQ:MBII)
finance.yahoo.com - November 7 at 9:53 AM
publicnow.com logoShe built a career on killing bugs without poison (NASDAQ:MBII)
www.publicnow.com - October 21 at 6:03 PM

Social

What is Marrone Bio Innovations' stock symbol?

Marrone Bio Innovations trades on the NASDAQ under the ticker symbol "MBII."

Where is Marrone Bio Innovations' stock going? Where will Marrone Bio Innovations' stock price be in 2017?

4 equities research analysts have issued twelve-month target prices for Marrone Bio Innovations' shares. Their predictions range from $1.00 to $3.50. On average, they expect Marrone Bio Innovations' share price to reach $2.33 in the next twelve months.

When will Marrone Bio Innovations announce their earnings?

Marrone Bio Innovations is scheduled to release their next quarterly earnings announcement on Tuesday, March, 28th 2017.

How do I buy Marrone Bio Innovations stock?

Shares of Marrone Bio Innovations can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Marrone Bio Innovations stock cost?

One share of Marrone Bio Innovations stock can currently be purchased for approximately $2.06.

Marrone Bio Innovations (NASDAQ:MBII) Chart for Monday, February, 27, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Marrone Bio Innovations (NASDAQ:MBII)

Earnings History Chart

Earnings by Quarter for Marrone Bio Innovations (NASDAQ:MBII)

Dividend History Chart

Dividend Payments by Quarter for Marrone Bio Innovations (NASDAQ:MBII)

Last Updated on 2/27/2017 by MarketBeat.com Staff